News Releases

Below are the latest News Releases for Clearmind Medicine Inc.

21

March

2025

Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S.
Read More
19

March

2025

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination
Read More
18

March

2025

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients
Read More
10

March

2025

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea
Read More
4

February

2025

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
Read More
6

January

2025

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
Read More
2

January

2025

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office
Read More
24

December

2024

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Read More
16

December

2024

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol (...)
Read More
10

October

2024

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
Read More
16

September

2024

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
Read More
12

September

2024

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
Read More
6

September

2024

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
Read More
29

August

2024

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
Read More
21

August

2024

Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment
Read More